Table 2.
n | % | |
---|---|---|
Article setting (n = 157) | ||
U.S. | 95 | 61 |
Non-U.S. | 62 | 39 |
Type of article (U.S. only, n = 95) | ||
Research | 36 | 38 |
Programmatic | 34 | 36 |
Synthesis of research | 25 | 26 |
Selected characteristics (Research only, n = 36) | ||
Research stage | ||
Evidence prioritization | 6 | 17 |
Evidence generation | 26 | 72 |
Evidence synthesis | 0 | 0 |
Evidence interpretation and integration | 0 | 0 |
Dissemination and Application | 3 | 8 |
Feedback and Assessment | 1 | 3 |
Type of methodology used | ||
Qualitative | 11 | 31 |
Quantitative | 4 | 11 |
Mixed methods | 14 | 39 |
ND* | 7 | 19 |
Study setting | ||
Community | 28 | 78 |
Health care setting | 6 | 17 |
NA* | 2 | 6 |
Unit of analysis | ||
Current patients | 7 | 19 |
Population (Public health), including community individuals | 19 | 53 |
Providers and provider organizations (hospitals, health centers…) | 5 | 14 |
Other** | 5 | 14 |
This table presents characteristics of 157 U.S. and non-U.S. research articles, program reports, and syntheses of research and programs that were included in the full text review. *NA and ND responses include articles in Stages 1 and 6, where a formal research may have not been presented. **Other includes miscellaneous responses, such as members of a collaborative, geographic/administrative boundaries, etc.